Amgen (NASDAQ:AMGN – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 22.300-23.500 for the period, compared to the consensus estimate of 22.390. The company issued revenue guidance of $38.2 billion-$39.4 billion, compared to the consensus revenue estimate of $37.8 billion. Get Amgen alerts:Get Our Latest Stock Analysis on AMGNAmgen Stock Up 5.0%Shares of NASDAQ:AMGN traded up $19.69 during mid-day trading on Wednesday, hitting $409.71. Amgen Company Profile(Get Free Report)Amgen Inc (NASDAQ: AMGN) is a global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California.